Appetite suppression and early satiety induced by GLP-1 receptor agonists can lead to reduced caloric and protein intake, increasing the risk of micronutrient deficiencies (notably vitamin D, B12, calcium, iron, magnesium, and zinc) and sarcopenia, especially during rapid or substantial weight loss
Standard semaglutide titration The typical schedule starts at 0.25mg weekly for the first 4 weeks, then increases to 0.5mg for weeks 5 through 8, then 1mg, 1.7mg, and eventually 2.4mg (the maximum approved dose for weight management)
And that's what GLP-1 is about
Human autoinflammatory diseases mediated by NLRP3-, Pyrin-, NLRP1-, and NLRC4-inflammasome dysregulation updates on diagnosis, treatment, and the respective roles of IL-1 and IL-18